Aminoglycoside Antibiotics: Structural Decoding of Inhibitors Targeting the Ribosomal Decoding a Site

Antibiotics: Targets, Mechanisms and Resistance

Volumn , Issue , 2013, Pages 453-470

  Kondo, Jiro ^a   Westhof, Eric ^b  

^a SOPHIA UNIVERSITY   (Japan)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84932621922     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527659685.ch19     Document Type: Chapter

References (68)

1. Ogle, J.M., Brodersen, D.E., Clemons, W.M. Jr., Tarry, M.J., Carter, A.P., and Ramakrishnan, V. (2001) Recognition of cognate transfer RNA by the 30S ribosomal subunit. Science, 292, 897-902.
2. Ogle, J.M., Carter, A.P., and Ramakrishnan, V. (2003) Insights into the decoding mechanism from recent ribosome structures. Trends Biochem. Sci., 28, 259-266.
3. Ogle, J.M., Murphy, F.V., Tarry, M.J., and Ramakrishnan, V. (2002) Selection of tRNA by the ribosome requires a transition from an open to a closed form. Cell, 111, 721-732.
4. Ogle, J.M. and Ramakrishnan, V. (2005) Structural insights into translational fidelity. Annu. Rev. Biochem., 74, 129-177.
5. Kondo, J. and Westhof, E. (2007) in Aminoglycoside Antibiotics from Chemical Biology to Drug Discovery (ed D.P. Arya), Wiley-Interscience, Hoboken, NJ, pp. 209-223.
6. Hobbie, S.N., Pfister, P., Brüll, C., Westhof, E., and Böttger, E.C. (2005) Analysis of the contribution of individual substituents in 4,6-aminoglycosideribosome interaction. Antimicrob. Agents Chemother., 49, 5112-5118.
7. Hobbie, S.N., Pfister, P., Bruell, C., Sander, P., François, B., Westhof, E., and Böttger, E.C. (2006) Binding of neomycin-class aminoglycoside antibiotics to mutant ribosomes with alterations in the A site of 16S rRNA. Antimicrob. Agents Chemother., 50, 1489-1496.
8. Recht, M.I., Douthwaite, S., and Puglisi, J.D. (1999) Basis for prokaryotic specificity of action of aminoglycoside antibiotics. EMBO J., 18, 3133-3138.
9. Hobbie, S.N., Akshay, S., Kalapala, S.K., Bruell, C.M., Shcherbakov, D., and Böttger, E.C. (2008) Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity. Proc. Natl. Acad. Sci. U.S.A., 105, 20888-20893.
10. Hobbie, S.N., Kalapala, S.K., Akshay, S., Bruell, C., Schmidt, S., Dabow, S., Vasella, A., Sander, P., and Böttger, E.C. (2007) Engineering the rRNA decoding site of eukaryotic cytosolic ribosomes in bacteria. Nucleic Acids Res., 35, 6086-6093.
11. Griffey, R.H., Hofstadler, S.A., Sannes-Lowery, K.A., Ecker, D.J., and Crooke, S.T. (1999) Determinants of aminoglycoside-binding specificity for rRNA by using mass spectrometry. Proc. Natl. Acad. Sci. U.S.A., 96, 10129-10133.
12. Nudelman, I., Rebibo-Sabbah, A., Shallom-Shezifi, D., Hainrichson, M., Stahl, I., Ben-Yosef, T., and Baasov, T. (2006) Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations. Bioorg. Med. Chem. Lett., 16, 6310-6315.
13. Carter, A.P., Clemons, W.M., Brodersen, D.E., Morgan-Warren, R.J., Wimberly, B.T., and Ramakrishnan, V. (2000) Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature, 407, 340-348.
14. Vicens, Q. and Westhof, E. (2001) Crystal structure of paromomycin docked into the eubacterial ribosomal decoding A site. Structure, 9, 647-658.
15. Vicens, Q. and Westhof, E. (2002) Crystal structure of a complex between the aminoglycoside tobramycin and an oligonucleotide containing the ribosomal decoding A site. Chem. Biol., 9, 747-755.
16. Vicens, Q. and Westhof, E. (2003) Crystal structure of geneticin bound to a bacterial 16S ribosomal RNA A site oligonucleotide. J. Mol. Biol., 326, 1175-1188.
17. François, B., Szychowski, J., Adhikari, S.S., Pachamuthu, K., Swayze, E.E., Griffey, R.H., Migawa, M.T., Westhof, E., and Hanessian, S. (2004) Antibacterial aminoglycosides with a modified mode of binding to the ribosomal-RNA decoding site. Angew. Chem. Int. Ed., 43, 6735-6738.
18. François, B., Russell, R.J.M., Murray, J.B., Aboul-ela, F., Masquida, B., Vicens, Q., and Westhof, E. (2005) Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding. Nucleic Acids Res., 33, 5677-5690.
19. Kondo, J., François, B., Russell, R.J., Murray, J.B., and Westhof, E. (2006) Crystal structure of the bacterial ribosomal decoding site complexed with amikacin containing the γ-amino-α-hydroxybutyryl (haba) group. Biochimie, 88, 1027-1031.
20. 2 ether analogues of paromomycin. J. Med. Chem., 50, 2352-2369.
21. Kondo, J., Pachamuthu, K., François, B., Szychowski, J., Hanessian, S., and Westhof, E. (2007) Crystal structure of the bacterial ribosomal decoding site complexed with a synthetic doubly functionalized paromomycin derivative: a new specific binding mode to an a-minor motif enhances in vitro antibacterial activity. ChemMedChem, 2, 1631-1638.
22. Hanessian, S., Pachamuthu, K., Szychowski, J., Giguère, A., Swayze, E.E., Migawa, M.T., François, B., Kondo, J., and Westhof, E. (2010) Structurebased design, synthesis and A-site rRNA co-crystal complexes of novel amphiphilic aminoglycoside antibiotics with new binding modes: a synergistic hydrophobic effect against resistant bacteria. Bioorg. Med. Chem. Lett., 20, 7097-7101.
23. 2-ether analogues. ChemMedChem, 6, 1961-1966.
24. Han, Q., Zhao, Q., Fish, S., Simonsen, K.B., Vourloumis, D., Froelich, J.M., Wall, D., and Hermann, T. (2005) Molecular recognition by glycoside pseudo base pairs and triples in an apramycin-RNA complex. Angew. Chem. Int. Ed., 44, 2694-2700.
25. Zhao, F., Zhao, Q., Blount, K.F., Han, Q., Tor, Y., and Hermann, T. (2005) Molecular recognition of RNA by neomycin and a restricted neomycin derivative. Angew Chem. Int. Ed., 44, 5329-5334.
26. Hermann, T. (2006) A-site model RNAs. Biochimie, 88, 1021-1026.
27. Dibrov, S.M., Parsons, J., and Hermann, T. (2010) A model for the study of ligand binding to the ribosomal RNA helix h44. Nucleic Acids Res., 38, 4458-4465.
28. Pape, T., Wintermeyer, W., and Rodnina, M.V. (2000) Conformational switch in the decoding region of 16S rRNA during aminoacyl-tRNA selection on the ribosome. Nat. Struct. Biol., 7, 104-107.
29. Demeshkina, N., Jenner, L., Westhof, E., Yusupov, M., and Yusupova, G. (2012) A new understanding of the decoding principle on ribosome. Nature, 484, 256-259.
30. Kondo, J. (2012) A structural basis for the antibiotic resistance conferred by an A1408G mutation in 16S rRNA and for the antiprotozoal activity of aminoglycosides. Angew. Chem. Int. Ed., 51, 465-468.
31. Kondo, J., Urzhumtsev, A., and Westhof, E. (2006) Two conformational states in the crystal structure of the Homo sapiens cytoplasmic ribosomal decoding A site. Nucleic Acids Res., 34, 676-685.
32. Kondo, J., François, B., Urzhumtsev, A., and Westhof, E. (2006) Crystal structure of the Homo sapiens cytoplasmic ribosomal decoding site complexed with apramycin. Angew. Chem. Int. Ed., 45, 3310-3314.
33. Kondo, J., Hainrichson, M., Nudelman, I., Shallom-Shezifi, D., Barbieri, C.M., Pilch, D.S., Westhof, E., and Baasov, T. (2007) Differential selectivity of natural and synthetic aminoglycosides towards the eukaryotic and prokaryotic decoding A sites. ChemBioChem, 8, 1700-1709.
34. Hermann, T., Tereshko, V., Skripkin, E., and Patel, D.J. (2007) Apramycin recognition by the human ribosomal decoding site. Blood Cells Mol. Dis., 38, 193-198.
35. Kondo, J. and Westhof, E. (2008) The bacterial and mitochondrial ribosomal Asite molecular switches possess different conformational substrates. Nucleic Acids Res., 36, 2654-2666.
36. Sander, P., Springer, B., Prammananan, T., Sturmfels, A., Kappler, M., Pletschette, M., and Böttger, E.C. (2002) Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob. Agents Chemother., 46, 1204-1211.
37. Shcherbakov, D., Akbergenov, R., Matt, T., Sander, P., Andersson, D.I., and Böttger, E.C. (2010) Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in-vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosis. Mol. Microbiol., 77, 830-840.
38. Kondo, J., Koganei, M., and Kasahara, T. (2012) Crystal structure and specific binding mode of sisomicin to the bacterial ribosomal decoding site. ACS Med. Chem. Lett., 3, 741-744.
39. Tor, Y., Hermann, T., and Westhof, E. (1998) Deciphering RNA recognition: aminoglycoside binding to the hammerhead ribozyme. Chem. Biol., 5, R277-R283.
40. Shakya, T. and Wright, G.D. (2007) in Aminoglycoside Antibiotics from Chemical Biology to Drug Discovery (ed D.P. Arya), Wiley-Interscience, Hoboken, NJ, pp. 119-140.
41. Hainrichson, M., Nudelman, I., and Baasov, T. (2007) Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases. Org. Biomol. Chem., 6, 227-239.
42. Hermann, T. (2007) Aminoglycoside antibiotics: old drugs and new therapeutic approaches. Cell. Mol. Life Sci., 64, 1841-1852.
43. Zhou, J., Wang, G., Zhang, L.H., and Ye, X.S. (2007) Modifications of aminoglycoside antibiotics targeting RNA. Med. Res. Rev., 27, 279-316.
44. Kawaguchi, H., Naito, T., Nakagawa, S., and Fujisawa, K. (1972) BB-K8, a new semisynthetic aminoglycoside antibiotic. J. Antibiot., 25, 695-708.
45. Kawaguchi, N. (1976) Discovery, chemistry, and activity of amikacin. J. Infect. Dis., 134, S242-S248.
46. Kondo, S. and Hotta, K. (1999) Semisynthetic aminoglycoside antibiotics: development and enzymatic modifications. J. Infect. Chemother., 5, 1-9.
47. Kotra, L.P., Haddad, J., and Mobashery, S. (2000) Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance. Antimicrob. Agents Chemother., 44, 3249-3256.
48. Haddad, J., Kotra, L.P., Llano-Sotelo, B., Kim, C., Azucena, E.F. Jr., Liu, M., Vakulenko, S.B., Chow, C.S., and Mobashery, S. (2002) Design of novel antibiotics that bind to the ribosomal acyltransfer site. J. Am. Chem. Soc., 124, 3229-3237.
49. Russell, R.J., Murray, J.B., Lentzen, G., Haddad, J., and Mobashery, S. (2003) The complex of a designer antibiotic with a model aminoacyl site of the 30S ribosomal subunit revealed by X-ray crystallography. J. Am. Chem. Soc., 125, 3410-3411.
50. Murray, J.B., Meroueh, S.O., Russell, R.J., Lentzen, G., Haddad, J., and Mobashery, S. (2006) Interactions of designer antibiotics and the bacterial ribosomal aminoacyl-tRNA site. Chem. Biol., 13, 129-138.
51. Schatz, A., Bugie, E., and Waksman, S.A. (1944) Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria. Proc. Soc. Exp. Biol. Med., 55, 66-69.
52. Karimi, R. and Ehrenberg, M. (1994) Dissociation rate of cognate peptidyltRNA from the A-site of hyper-accurate and error-prone ribosomes. Eur.J. Biochem., 226, 335-360.
53. Karimi, R. and Ehrenberg, M. (1996) Dissociation rates of peptidyl-tRNA from the P-site of E. coli ribosomes. EMBO J., 15, 1149-1154.
54. Lodmell, J.S. and Dahlberg, A.E. (1997) A conformational switch in Escherichia coli 16S ribosomal RNA during decoding of messenger RNA. Science, 277, 1262-1267.
55. Gonzalez, A., Jimenez, A., Vazquez, D., Davies, J.E., and Schindler, D. (1978) Studies on the mode of action of hygromycin B, an inhibitor of translocation in eukaryotes. Biochim. Biophys. Acta, 521, 459-469.
56. Brodersen, D.E., Clemons, W.M. Jr., Carter, A.P., Morgan-Warren, R.J., Wimberly, B.T., and Ramakrishnan, V. (2000) The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell, 103, 1143-1154.
57. Hirokawa, G., Kiel, M.C., Muto, A., Selmer, M., Raj, V.S., Liljas, A., Igarashi, K., Kaji, H., and Kaji, A. (2002) Post-termination complex disassembly by ribosome recycling factor, a functional tRNA mimic. EMBO J., 21, 2272-2281.
58. Borovinskaya, M.A., Pai, R.D., Zhang, W., Schuwirth, B.S., Holton, J.M., Hirokawa, G., Kaji, H., Kaji, A., and Cate, J.H. (2007) Structural basis for aminoglycoside inhibition of bacterial ribosome recycling. Nat. Struct. Mol. Biol., 14, 727-732.
59. Bilgin, N., Richter, A., Ehrenberg, M., Dahlberg, A.E., and Kurland, C.G. (1990) Ribosomal RNA and protein mutants resistant to spectinomycin. EMBO J., 9, 735-739.
60. Borovinskaya, M.A., Shoji, S., Holton, J.M., Fredrick, K., and Cate, J.H. (2007) A steric block in translation caused by the antibiotic spectinomycin. ACS Chem. Biol., 2, 545-552.
61. Umezawa, H., Hamada, M., Suhara, Y., Hashimoto, T., and Ikekawa, T. (1965) Kasugamycin, a new antibiotic. Antimicrob. Agents Chemother., 5, 753-757.
62. Hamada, M., Hashimoto, T., Takahashi, T., Yokoyama, S., Miyake, M., Takeuchi, T., Okami, Y., and Umezawa, H. (1965) Antimicrobial activity of kasugamycin. J. Antibiot. Ser. A, 18, 104-106.
63. Schluenzen, F., Takemoto, C., Wilson, D.N., Kaminishi, T., Harms, J.M., Hanawa-Suetsugu, K., Szaflarski, W., Kawazoe, M., Shirouzu, M., Nierhaus, K.H., Yokoyama, S., and Fucini, P. (2006) The antibiotic kasugamycin mimics mRNA nucleotides to destabilize tRNA binding and inhibit canonical translation initiation. Nat. Struct. Mol. Biol., 13, 871-878.
64. Maxwell, I.H. (1967) Partial removal of bound transfer RNA from polysomes engaged in protein synthesis in vitro after addition of tetracycline. Biochim. Biophys. Acta, 138, 337-346.
65. Geigenmüller, U. and Nierhaus, K.H. (1986) Tetracycline can inhibit tRNA binding to the ribosomal P site as well as to the A site. Eur. J. Biochem., 161, 723-726.
66. Pioletti, M., Schlünzen, F., Harms, J., Zarivach, R., Glühmann, M., Avila, H., Bashan, A., Bartels, H., Auerbach, T., Jacobi, C., Hartsch, T., Yonath, A., and Franceschi, F. (2001) Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3. EMBO J., 20, 1829-1839.
67. Craveri, R., Coronelli, C., Pagani, H., and Sensi, P. (1964) Thermorubin, a new antibiotic from a thermoactinomycete. Clin. Med. (Northfield Il), 71, 511-521.
68. Bulkley, D., Johnson, F., and Steitz, T.A. (2012) The antibiotic thermorubin inhibits protein synthesis by binding to inter-subunit bridge B2a of the ribosome. J. Mol. Biol., 416, 571-578.